Kenney Christopher John
- SEC CIK
- 0001880129
In the past year, 3 open-market sale filings worth $670.3K and no purchases.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Chief Medical Officeras of Aug 31, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $670.3K
- 3 filings
- Net
- −$670.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kenney Christopher John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)9:59 PM ET | Aug 28 | 3 days | Kenney Christopher JohnChief Medical Officer | SSale | −7.07K | $60.25 | −$425.8K | −100.0%2 after | 2 lots10b5-1 |
| Mar 13, 2026 (view filing) | Mar 13 | Same day | Kenney Christopher JohnChief Medical Officer | SSale | −1.41K | $55.23 | −$77.9K | −16.6%7.07K after | 10b5-1 |
| Mar 11, 2026 (view filing) | Mar 10 | 1 day | Kenney Christopher JohnChief Medical Officer | SSale | −2.77K | $60.11 | −$166.6K | −36.9%4.73K after | 10b5-1 |
| Mar 24, 2023 (view filing) | Mar 24 | Same day | Kenney Christopher JohnChief Medical Officer | SSale | −700 | $35.01 | −$24.5K | −100.0%0 after | |
| Jan 21, 2022 (view filing) | Jan 21 | Same day | Kenney Christopher JohnChief Medical Officer | PPurchase | +700 | $28.81 | +$20.2K | New position700 after |